相关产品推荐更多 >

CLIP Antibody, anti-human, PE, REAfinity™, 100 tests in 1 mL
询价
CD22 Antibody, anti-human, VioBlue®, REAfinity™, 100 tests in 200 µL
询价
CD52 Antibody, anti-human, Biotin, REAfinity™, 100 tests in 1 mL
询价
CD4 Antibody, anti-human, APC, REAlease®, 30 tests in 60 µL
询价
CD204 Antibody, anti-mouse, FITC, REAfinity™, 30 µg in 1 mL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Podoplanin
- 形态:
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件:
避光,4-8℃
- 克隆性:
REAL1387
- 标记物:
PE
- 适应物种:
mouse
- 保质期:
24个月
- 供应商:
Miltenyi biotec
- 宿主:
cell line
- 应用范围:
MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
- 抗体英文名:
Podoplanin Antibody, anti-mouse, REAdye_lease™
- 抗体名:
Podoplanin Antibody, anti-mouse, REAdye_lease™
- 规格:
200 µL
Detection of Podoplanin+ cellsClone REAL1387 is an antibody fragment derived from the full mouse Podoplanin antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL1387 recognizes Podoplanin, a mucin-type glycoprotein thought to be involved in the development of the lymphatic vascular system. Podoplanin mediates effects on cell migration and adhesion through its different partners and has a potential role in tumor progression. During development it plays a role in blood and lymphatic vessels separation by binding CLEC1B, triggering CLEC1B activation in platelets and leading to platelet activation and/or aggregation. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675). |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Bieniasz-Krzywiec, P. et al. (2019) Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer. Cell Metab. 30 (5): 917–936. | Suzuki-Inoue, K. (2019) Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. Blood 134 (22): 1912–1918. | Ukaji, T. et al. (2021) Novel knock-in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin-targeting agents. Cancer Sci. 112 (6): 2299–2313.
技术资料暂无技术资料 索取技术资料
文献支持
Podoplanin Antibody, anti-mouse, PE, REAdye_lease™, 200 µL
询价





